08:21 AM EDT, 07/26/2024 (MT Newswires) -- Insulet ( PODD ) shares were up 5.2% in recent Friday premarket activity after the company reported preliminary Q2 revenue of $488 million, compared with $397 million a year earlier.

Analysts polled by Capital IQ expect $461.3 million.

The company, which will post its Q2 results on Aug. 8, said it expects the revenue for its insulin pump technology Omnipod to have risen 26% to $480 million during the quarter.

Insulet ( PODD ) also said it will likely lift the fiscal 2024 Omnipod revenue guidance to an 18%-to-21% range, up from 15% to 19% anticipated previously.

Price: 200.80, Change: +9.92, Percent Change: +5.20